Biopolymers augment viral vectors based gene delivery
J Biosci
;
2019 Sep; 44(4): 1-8
Artigo
| IMSEAR
| ID: sea-214428
ABSTRACT
The success of viral vectors mediated gene therapy is still hampered by immunogenicity and insufficient transgeneexpression. Alternatively, non-viral vectors mediated gene delivery has the advantage of low immunogenicity despiteshowing low transgene expression. By carefully considering the advantages of each approach, hybrid vectors are currentlybeing developed by modifying the viral vectors using non-viral biopolymers. This review provides an overview of thehybrid vectors currently being developed.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Revista:
J Biosci
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS